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Executive Summary
Reducing surgical site infections allows for a tremendous reduction in healthcare costs,
reduces length of hospital stay, decreases hospital readmissions, and promotes patient safety. The
Centers for Disease Control and Prevention estimates that surgical site infections have a 3%
mortality rate and 75% of all surgical site infection-related deaths are directly attributable to the
surgical site infection (Centers for Disease Control and Prevention [CDC], 2020). With millions
of surgeries being performed every year, the reduction of surgical site infections enhances patient
safety and ensures the protection of the public. Currently, no standard protocol exists for skin
preparation beyond the parameters of maintaining sterile technique throughout the skin
preparation, patient allergies, and surgeon preference. To accurately assess one type of skin
solution over another, one must ensure the technique used to sterilely prepare the patient is
consistently being performed correctly. This encompasses the use of education in evidence-based
practice and requires the input and commitment of educators and stakeholders throughout the
process.
A project evaluating the efficacy of an alcohol-based surgical skin preparation solution
versus an alcohol and iodine combination skin preparation solution is necessary to standardize
skin preparation for surgery. Current evidence suggests using both alcohol and iodine to attain
skin asepsis prior to incision will provide superior protection against surgical site infections.
Developing a standardized use of an evidence-based skin preparation solution will potentially
lead to a decrease in post-operative infection in the clinical setting.
1. Rationale for the Project
Different types of surgical skin preparation solutions impact the risk of surgical site
infections as a myriad of differing types of skin preparation solutions exist. Some skin aseptic

REDUCING SURGICAL SITE INFECTIONS
solutions possess varying percentages of alcohol, others consist of betadine scrub solution and
paint, and some contain a combination of alcohol and iodine. As the Centers for Medicaid and
Medicare Services does not reimburse for infections acquired while in the hospital, surgical site
infections have gained notice in the healthcare industry. The use of alcohol-based skin
preparation solutions has increased drastically over the last decade with the advent of
Chloraprep, though little research has been done to validate its frequency of use in surgical cases.
Betadine has historically been considered the standard for skin asepsis in surgery; however, that
does not necessarily imply that iodine-based skin preparation solutions are the best practice. A
comparison between an alcohol-based skin preparation solution alone versus an alcohol and
iodine skin preparation is necessary to determine overall patient outcomes. Since alcohol skin
solutions and iodine skin solutions work in different ways, the use of the two reagents combined
should result in fewer post-operative infections. Reducing the rate of surgical site infections is an
ongoing initiative designed to reduce cost, decrease hospital readmissions, and provide better
patient care. Designing a benchmark study in which the use of an evidence-based skin
preparation solution can potentially lead to a decrease in post-operative infection in the clinical
setting.
2. Synthesis of Literature
Surgical site infections have been studied relentlessly for decades; causes, prevention,
and techniques designed to reduce surgical site infections have been evaluated extensively
throughout the last half century. An examination of the types of surgical skin preparations which
provide the strongest efficacy in eliminating skin flora, thereby reducing the risk of surgical site
infections has also been a topic of interest among many in the field of surgery. The advent of
alcohol-based skin preparations such as Chloraprep created much discussion between the use of
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alcohol in skin asepsis and the use of iodine-based skin preparation solutions. Starting in 1970, a
myriad of comparisons has been made over the years comparing alcohol, iodine, and a
combination of the two to determine which solution is the most effective at eliminating bacteria
from the skin prior to incision. Some studies compared sequential use of solutions, for example,
prepping the skin with alcohol and subsequently prepping the skin with an iodine-solution.
Others contrasted the use of Chloraprep and Duraprep, an alcohol and iodine containing solution.
For this benchmark study, a comparison is made between the efficacy of Chloraprep and
Duraprep.
In 2016, Davies and Patel examined the rate of surgical site infections in patients
undergoing craniotomies; their basis for evaluating the efficacy stemmed from the concept that
iodine and alcohol eliminate bacteria through different mechanisms, thus the use of both alcohol
and iodine would allow better protection against a surgical site infection. The results revealed
that a combination skin preparation significantly reduced the incidence of surgical site infections
following craniotomies. In addition to reducing surgical site infections in neurosurgery patients,
cardiac patients were studied and while the presence of incisional infections remained the same
in both cohort groups, organ space infections showed a decrease when both alcohol and iodine
were used as a skin preparation for patients undergoing cardiac surgery (Raja et al., 2018).
Orthopedic surgeries carry a unique risk for a surgical site infection because they often
require the use of implants. Implantable devices are foreign to the body and increase the chance
of a surgical site infection. Peel et al. (2019) determined through a randomized controlled trial
that the use of iodine and was superior to reducing the incidence of surgical site infections in
joint arthroplasties. This is a similar finding to the randomized controlled trial of Xu, Fowler, and
Goitz (2017) when examining the efficacy of alcohol and iodine for elective hand surgeries.
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A careful review of all relevant literature pertaining to surgical skin preparation solutions
and the incidence of surgical site infections was done by Davies and Patel in 2016, where the
results indicated the use of alcohol and iodine combined reduced the rate of surgical site
infections. Mermel repeated a systematic review in 2019 and the results overwhelmingly
supported the use of both iodine and alcohol to reduce the rate of surgical site infections.
3. Stakeholders
Stakeholders operate in the best interest of an organization. Prior to facilitating
organizational change, stakeholders should be identified and profiled to promote more effective
communication throughout change initiatives. The stakeholders are the individuals from whom
the patient receives care, and while the definition of stakeholders can be extended to include
hospital administrators, the marketing department, or financial committees in a facility, regarding
this benchmark study, the primary stakeholders are defined as physicians, anesthesiologists,
perioperative nurses, and surgical technologists. Each participant has their own role, and each
member of the surgical team is equally committed to a safe, uncomplicated surgery. All members
of the patient care team have a responsibility to inform the patient of what to expect throughout
the surgical process; the physician has a duty to educate the patient on the benefits and harms of
a surgical intervention (Elwyn et al., 2016). Thus, the roles of the stakeholders within the
surgical unit include: the physician anticipating that the patient will have a positive outcome
from the surgery, anesthesia limiting the patient’s pain post-operatively while safely
administering anesthesia throughout the surgery. The surgical nurse is responsible for ensuring
all documentation is correct, all specimens are accurate, and the patient’s loved ones are updated
on a consistent basis. The surgical technologist retains track of instruments and countable items,
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collects specimens, and maintains vigilance over the sterile field. All components work together
for a safe, accurate surgery that will result in a positive patient outcome.
4. Implementation
The initial phase of implementation involves gaining the participation of stakeholders;
upon approval from the facility, three to five surgeons willing to participate in this study must be
identified. The surgeons must agree to use both types of skin preps on their surgical cases, an
alcohol-based prep such as Chloraprep, and an alcohol and iodine prep, such as Duraprep. The
surgeons will then be educated on what is being studied, why, and which kind of patients would
be an acceptable fit for this study. Healthy patients with limited comorbidities and no active
infection are the target subjects for this study. The patients will be followed and assessed for a
surgical site infection over a three month period post-operatively. The procedures must be either
the same or closely similar and cannot involve an implant, since the risk of infection increases
with surgical procedures that involve implants. Surgeries such as an open abdominal
hysterectomy or an open ventral hernia repair are the focus of this study as these cases are
considered “clean” surgical cases yet are higher in risk for surgical site infections due to the large
incision. No “dirty” cases such as colectomies will be permitted since they are the highest at risk
for surgical site infections. Once we have gained a commitment from surgeons to participate,
education of the staff will begin. Education for the surgical staff on the reduction of surgical site
infections through the selection of a skin preparation solution will be the subsequent step in the
implementation process. A patient consent form must be drafted and receive approval from the
facility; the perioperative educator will then educate the nurses on when the consent will be used
and how to ensure its completion. The Day Surgery department as well as members of the
surgeons’ office staff will need to be educated on the patient consent form as they will also be
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responsible for obtaining consent. The perioperative educator will assess the current technique of
surgical skin preparation by the staff and begin to teach all perioperative nurses a uniform
method to avoid improper technique being a variable in this study. Once a uniform technique has
been achieved, the data collection can begin.
Communication with the selected surgeons is paramount as a list of optimal candidates who
fit the criteria of being healthy with no active infections is created. If additional candidates arise
during the study, the surgeon will contact the leader of the project, who will assign a specific skin
preparation solution for the surgery. Consent from the patient must be obtained; this can be done
in the surgeons’ office at the time the surgery is scheduled, or in when the patient arrives for
surgery. If it is done at the surgeon’s office, it will need to be faxed to the facility along with the
physician’s orders for surgery. If it is to be done at the time of arrival for surgery, a consent
should be placed in the patient’s chart to be completed. Half of the patients will be sterilely
prepped with Chloraprep, and the other half of the patients will be sterilely prepped with
Duraprep. The patients will then be followed post-operatively for any signs of surgical site
infections such as redness, swelling, discharge, pain at the incision site, or fever. Follow up will
occur every two days for the first two weeks following surgery and will be weekly for the
remainder of the three months.
5. Timetable/Flowchart
Due to the low surgical census because of Covid, a benchmark project was selected as the
best course of action for this study. In previous semesters, the plan was to collect data from
surgeries over the course of a three month period, beginning in late August and continuing
through November. Careful consideration of this timeframe reveals it to be insufficient in length
and should it be approved by the facility and implemented in the future, would require an
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extended timeframe of six months to allow for appropriate data collection. Regarding this
benchmark project, three months was allotted to gather post-operative data from selected
patients. Table 1 represents the time frame to be anticipated for this study, beginning with the
planning phase, and following through to the dissemination phase.
Table 1
Four Phases and Timeline of Benchmark Project to Reduce Surgical Site Infections

•
•
•
•

Planning

Implementing

Evaluating

Marketing

Two weeks

Twelve weeks

One week

One week

Form an interprofessional
team
Assessment of
current data
Education for
participating
staff
Recruitment of
physicians

•

•

Implement the
project change
by prepping
patient with
alcohol and
iodine based skin
preps
Track progress
of patients postoperatively

•
•

Evaluate the rate
of surgical site
infections
Evaluate cost
savings related to
a reduction in
surgical site
infections

•
•

Disseminate
findings
Determine how
to market the
evidence to
promote a
permanent,
sustainable
practice change

6. Data Collection Methods
The benchmark study allowed for a literature review as a means of data collection.
Should the benchmark study receive approval from the facility and be implemented, the data
collection period will ideally occur over a six month period. The conclusions needed to
determine if the change was successful will be a reduction in surgical site infections as evidenced
by patient outcomes, decreased hospital stay, and no subsequent surgical procedures needed after
the initial surgery. Patients recovering in the facility will be monitored for fever, purulent
discharge, and redness and swelling as evidence of a post-operative infection. Patients who are
discharged can be evaluated for a surgical site infection via telephone and in addition, at their
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scheduled follow up appointment with their surgeon. The patients will be followed for three
months post-operatively. Follow up will occur every two days for the first two weeks following
surgery and will be weekly for the remainder of the three months. After collecting data from the
patients at the end of three months, evaluation of which skin solution showed less surgical site
infections can begin. Examine the success of the data collection methods by determining if any
participants were lost due to lack of follow up or if any of the participants were eliminated for
extenuating reasons. The skin solution that demonstrated the least number of surgical
complications can be declared more effective at preventing surgical site infections and
dissemination of this knowledge can begin.
7. Cost/Benefit
The cost of implementing this project is low as the only costs incurred are the costs
associated with an additional consent. Pre-operative skin preparation is a standard of practice for
perioperative nurses and therefore, the wages of nurses should not be factored into the costs of
this project. Both surgical skin preparation solutions are readily available at every facility
nationwide and therefore, additional revenue will not be necessary for the purchase of
Chloraprep or Duraprep. The potential benefits from this benchmark project are substantial as
surgical site infections result in significantly higher costs, are associated with increased
morbidity and mortality, and extended length of stay post-operatively. In addition to posing a
threat to patients, the costs associated with surgical site infections has been estimated to add
$20,000 per admission while adding on an additional 9.7 days to each patient hospital stay
(Fields et al., 2020). Since Centers for Medicare and Medicaid Services began declining
reimbursements for hospital acquired conditions in 2008, the burden of cost rests upon the
hospital facility (Centers for Medicare and Medicaid Services [CMS], 2020). The average annual
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costs resulting from surgical site infections is estimated to be $3.3 billion, with much of the cost
being passed to the hospital facility, where it is then passed on to the consumer, resulting in an
increase in the cost of healthcare for everyone (CDC, 2020).
8.Discussion/Results
The results of this benchmark study are not available for evaluation and are predicated
upon literature review. While there exists some resistance to establishing a standardization for
skin preparation prior to surgery, there has also been positive feedback from many surgeons
when queried about examining which skin solution was more efficacious at preventing surgical
site infections. A goal of this benchmark study is to continue to promote a standardized protocol
predicated upon evidence-based practice to promote safer patient outcomes.
Recommendations
Surgical site infections lead to increased patient and facility costs, lengthened hospital
stays, and increase the risk of patient mortality. Changing the methods of skin preparation prior
to surgical incision will lead to a reduction in post-operative infections, resulting in millions of
dollars saved over time as patients are kept safer. Reducing surgical site infections should be a
priority for every facility as post-operative infections are the costliest hospital acquired condition
(CDC, 2020). The support of leadership is essential to participation in creative and dynamic
teams that advance innovation. Using persuasive and innovative skills to promote change within
in the department is the primary step. Once buy-in from leadership has occurred, a change
initiative with a team of inter-professionals including administration, staff, surgeons, and
perioperative educators to examine which surgical skin preparation solution is more effective at
preventing surgical site infections can begin. The objective is to establish one skin preparation
solution as superior over others and implement the use of the most effective solution as it will
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result in a reduction of surgical site infections, reduce healthcare costs, and improve patient
outcomes.
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